Similar articles

• Chemotherapy for endometrial carcinoma (GOGO-EM1 study): TEC (paclitaxel, epirubicin, and carboplatin) is an effective remission-induction and adjuvant therapy.

  Egawa-Takata T, Ueda Y, Kuragaki C, Miyake T, Miyatake T, Fujita M, Yoshino K, Nakashima R, Okazawa M, Tsutsui T, Morishige K, Kimura T, Yamasaki M, Nishizaki T, Nagamatsu M, Ito K, Asada M, Ogita K, Wakimoto A, Yamamoto T, Nishio Y, Enomoto T. Egawa-Takata T, et al. Cancer Chemother Pharmacol. 2011 Dec;68(6):1603-10. doi: 10.1007/s00280-011-1638-4. Epub 2011 May 17. Cancer Chemother Pharmacol. 2011. PMID: 21584840 Clinical Trial.
• Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.

  Papadimitriou CA, Bafaloukos D, Bozas G, Kalofonos H, Kosmidis P, Aravantinos G, Fountzilas G, Dimopoulos MA; Hellenic Co-operative Oncology Group. Papadimitriou CA, et al. Gynecol Oncol. 2008 Jul;110(1):87-92. doi: 10.1016/j.ygyno.2008.03.004. Epub 2008 May 2. Gynecol Oncol. 2008. PMID: 18455782 Clinical Trial.
• Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer.

  Lupe K, D'Souza DP, Kwon JS, Radwan JS, Harle IA, Hammond JA, Carey MS. Lupe K, et al. Gynecol Oncol. 2009 Jul;114(1):94-8. doi: 10.1016/j.ygyno.2009.03.027. Epub 2009 Apr 29. Gynecol Oncol. 2009. PMID: 19406459
• [Efficacy of cancer chemotherapy on patients with recurrent endometrial carcinoma].

  Kakinoki S, Takizawa K. Kakinoki S, et al. Nihon Rinsho. 2004 Oct;62 Suppl 10:365-9. Nihon Rinsho. 2004. PMID: 15535269 Review. Japanese. No abstract available.
• Chemotherapy for high-risk early-stage endometrial cancer.

  Kodama J, Seki N, Hiramatsu Y. Kodama J, et al. Curr Opin Obstet Gynecol. 2007 Feb;19(1):42-7. doi: 10.1097/GCO.0b013e32801127b7. Curr Opin Obstet Gynecol. 2007. PMID: 17218851 Review.